Digital Pathology Market

Executive Summary

Digital Pathology Market was valued at US $907.43 million in 2021 and is projected to grow at 13.60% CAGR over the forecast period to reach US $1,950.20 million by 2027. Digital Pathology Market represented US $204.26 million opportunity over 2019-2021 and estimated to create US $1,042.77 million opportunity in 2027 over 2021.

Digital Pathology from Consainsights analyses the Digital Pathology Market in the Life Sciences industry over the forecast period to 2027.

Digital Pathology research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Digital Pathology segmentation includes Product, Type, Application, End-user, Region and Geography.

Based on the Product, the Digital Pathology analysis covers Scanners, Software, Communication Systems, Storage Systems.

In Product segment, Scanners segment has highest cagr growth of 12.00%.

Based on the Type, the Digital Pathology analysis covers Human Pathology, Veterinary Pathology.

In Type segment, Human Pathology segment has highest cagr growth of 12.00%.

Based on the Application, the Digital Pathology analysis covers Drug Discovery, Disease Diagnosis, Teleconsultation, Training & Education.

In Application segment, Drug Discovery segment has highest cagr growth of 12.00%.

Based on the End-user, the Digital Pathology analysis covers Pharmaceutical & Biotechnology Companies, Hospitals & Reference Laboratories, Academic & Research Institutes.

In End-user segment, Pharmaceutical & Biotechnology Companies segment has highest cagr growth of 12.00%.

Based on the Region, the Digital Pathology analysis covers North America, Europe, Asia-Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 12.00%.

Based on the region, the Digital Pathology analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Scanners segment has the highest revenue of US $399.98 million and is expected to grow at CAGR of 12.00% by 2027 Scanners segment has highest cagr growth of 12.00%.

Scanners

Scanners segment was valued at US $309.94 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $859.61 million by 2027. Scanners segment represented US $90.04 million opportunity over 2019-2021 and estimated to create US $459.63 million opportunity in 2027 over 2021.

Software

Software segment was valued at US $212.96 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $590.63 million by 2027. Software segment represented US $61.86 million opportunity over 2019-2021 and estimated to create US $315.81 million opportunity in 2027 over 2021.

Communication Systems

Communication Systems segment was valued at US $89.52 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $248.29 million by 2027. Communication Systems segment represented US $26.01 million opportunity over 2019-2021 and estimated to create US $132.76 million opportunity in 2027 over 2021.

Storage Systems

Storage Systems segment was valued at US $90.74 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $251.67 million by 2027. Storage Systems segment represented US $26.36 million opportunity over 2019-2021 and estimated to create US $134.57 million opportunity in 2027 over 2021.

Type

Introduction

In 2021, Human Pathology segment has the highest revenue of US $617.24 million and is expected to grow at CAGR of 12.00% by 2027 Human Pathology segment has highest cagr growth of 12.00%.

Human Pathology

Human Pathology segment was valued at US $478.30 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $1,326.53 million by 2027. Human Pathology segment represented US $138.94 million opportunity over 2019-2021 and estimated to create US $709.29 million opportunity in 2027 over 2021.

Veterinary Pathology

Veterinary Pathology segment was valued at US $224.87 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $623.68 million by 2027. Veterinary Pathology segment represented US $65.32 million opportunity over 2019-2021 and estimated to create US $333.48 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Drug Discovery segment has the highest revenue of US $377.93 million and is expected to grow at CAGR of 12.00% by 2027 Drug Discovery segment has highest cagr growth of 12.00%.

Drug Discovery

Drug Discovery segment was valued at US $292.86 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $812.22 million by 2027. Drug Discovery segment represented US $85.07 million opportunity over 2019-2021 and estimated to create US $434.29 million opportunity in 2027 over 2021.

Disease Diagnosis

Disease Diagnosis segment was valued at US $204.82 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $568.06 million by 2027. Disease Diagnosis segment represented US $59.50 million opportunity over 2019-2021 and estimated to create US $303.74 million opportunity in 2027 over 2021.

Teleconsultation

Teleconsultation segment was valued at US $169.51 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $470.13 million by 2027. Teleconsultation segment represented US $49.24 million opportunity over 2019-2021 and estimated to create US $251.38 million opportunity in 2027 over 2021.

Training & Education

Training & Education segment was valued at US $35.98 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $99.79 million by 2027. Training & Education segment represented US $10.45 million opportunity over 2019-2021 and estimated to create US $53.36 million opportunity in 2027 over 2021.

End-user

Introduction

In 2021, Pharmaceutical & Biotechnology Companies segment has the highest revenue of US $495.01 million and is expected to grow at CAGR of 12.00% by 2027 Pharmaceutical & Biotechnology Companies segment has highest cagr growth of 12.00%.

Pharmaceutical & Biotechnology Companies

Pharmaceutical & Biotechnology Companies segment was valued at US $383.59 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $1,063.85 million by 2027. Pharmaceutical & Biotechnology Companies segment represented US $111.43 million opportunity over 2019-2021 and estimated to create US $568.84 million opportunity in 2027 over 2021.

Hospitals & Reference Laboratories

Hospitals & Reference Laboratories segment was valued at US $206.83 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $573.63 million by 2027. Hospitals & Reference Laboratories segment represented US $60.08 million opportunity over 2019-2021 and estimated to create US $306.72 million opportunity in 2027 over 2021.

Academic & Research Institutes

Academic & Research Institutes segment was valued at US $112.75 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $312.72 million by 2027. Academic & Research Institutes segment represented US $32.75 million opportunity over 2019-2021 and estimated to create US $167.21 million opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $411.54 million and is expected to grow at CAGR of 12.00% by 2027 North America segment has highest cagr growth of 12.00%.

North America

North America segment was valued at US $318.90 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $884.45 million by 2027. North America segment represented US $92.64 million opportunity over 2019-2021 and estimated to create US $472.91 million opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $215.32 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $597.17 million by 2027. Europe segment represented US $62.55 million opportunity over 2019-2021 and estimated to create US $319.30 million opportunity in 2027 over 2021.

Asia-Pacific

Asia-Pacific segment was valued at US $151.69 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $420.70 million by 2027. Asia-Pacific segment represented US $44.06 million opportunity over 2019-2021 and estimated to create US $224.95 million opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $17.27 million in 2019 and is projected to grow at 12.00% CAGR over the forecast period to reach US $47.88 million by 2027. Rest of the World segment represented US $5.02 million opportunity over 2019-2021 and estimated to create US $25.60 million opportunity in 2027 over 2021.